Diabetes and Menopause

@article{Ch2016DiabetesAM,
  title={Diabetes and Menopause},
  author={Vijayalakshmi Ch and rasekhar},
  journal={Journal of Anesthesia \& Critical Care: Open Access},
  year={2016},
  volume={6}
}
  • V. Ch, rasekhar
  • Published 13 December 2016
  • Medicine
  • Journal of Anesthesia & Critical Care: Open Access
Individuals with type 1 diabetes experience accelerated senescence Therefore, one would expect other indicators of biological age, such as the occurrence of the menopause transition, to begin prematurely among women with type 1 diabetes [3]. The mean age at natural menopause is statistically significantly for type 1 diabetic women compared with nondiabetic sisters or control subjects (41.6, 49.9, and 48.0 years, respectively, P = 0.05). This results in a 6-year reduction in the number of… 

References

SHOWING 1-10 OF 32 REFERENCES
Menopause in type 1 diabetic women: is it premature?
TLDR
It is hypothesize that an earlier menopause, which resulted in a 17% decrease in reproductive years, is a major unstudied complication of type 1 diabetes.
Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis of the Dutch DOM cohort
TLDR
Evidence is provided of the protective effect of lower age at menopause on subsequent breast cancer risk, and this protective effect may be even stronger in leaner women.
The Effects of Menopause on Autoimmune Diseases
TLDR
The effect of menopause on autoimmunity is an area well deserving of further research effort and has been challenged by the observation of undeniable contributions to autoimmune disease by genetics, immunosenescence, and environmental triggers as well.
Evaluation of bone loss in diabetic postmenopausal women
TLDR
Osteopenia and osteoporosis is more common in diabetic postmenopausal women compare to the non-diabetic post menopausal women.
Dyslipidemia in Menopause: Mechanisms and Management
TLDR
An overview of dyslipidemia, screening recommendations, interpretation of results, and management or referral of women who have modifiable risk factors for coronary artery disease is provided.
Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).
TLDR
It is shown that postmenopausal women with diabetes had increased dyslipidemia compared with nondiabetic women and current users of HRT had better lipoprotein profile than never or previous users ofHRT.
Diabetes and the risk of acute urinary tract infection among postmenopausal women.
TLDR
Diabetes under pharmacologic treatment is associated with increased risk of clinically apparent UTI in postmenopausal women with disease of shorter duration or longer duration.
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy.
TLDR
The results show that the kidney with type 2 diabetic nephropathy displays an accelerated senescent phenotype in defined renal cell types, mainly tubule cells and, to a lesser extent, podocytes, thus reinforcing the role of the metabolic syndrome on biological aging of tissues.
Estrogen Deficiency and the Origin of Obesity during Menopause
TLDR
A systematic review discusses the role of estrogens and estrogen receptors in adipocyte differentiation, and its control by the central nervous systemn and the possible role of estrogen-like compounds and endocrine disruptors chemicals are discussed.
Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis
TLDR
Screening for PCOS and androgen excess should be included in current guidelines for the management of type 1 diabetes in women, as it may contribute to the subfertility of these women by a mechanism that does not directly depend on glycemic/metabolic control among other negative consequences for their health.
...
...